Rhofade

Aclaris Therapeutics Inc (NASDAQ: ACRS) shares were seeing some upward momentum Tuesday on the back of the announcement of a patent win. What Happened The U.S. Patent and Trademark Office has granted the company a patent — No. 10,335,391 — covering the methods to treat facial...